DXC Total Non-Current Liabilities

DXC Technology Company Common Stock · Total Non-Current Liabilities

DXC logo

DXC Total Non-Current Liabilities

Latest reported$5.68B
DXC Quarterly Total Non-Current Liabilities ($48.10M → $5.68B)
High-resolution chart · PNG

DXC total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

DXC Technology Company Common Stock Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
5,682,000,000
5,742,000,000
5,855,000,000
5,237,000,000
5,511,000,000
5,304,000,000
5,993,000,000
6,264,000,000
6,157,000,000
6,411,000,000
6,565,000,000
6,264,000,000
6,157,000,000
6,838,000,000
7,132,000,000
6,936,000,000
7,341,000,000
7,911,000,000
8,138,000,000
8,213,000,000
8,075,000,000
8,580,000,000
9,369,000,000
12,263,000,000
14,627,000,000
12,982,000,000
11,714,000,000
11,672,000,000
12,022,000,000
8,430,000,000
8,993,000,000
8,531,000,000
7,998,000,000
10,232,000,000
10,742,000,000
11,232,000,000
10,780,000,000
3,547,000,000
3,452,000,000
3,793,000,000
3,865,000,000
3,166,000,000
3,172,000,000
3,590,000,000
3,569,000,000
3,651,000,000
4,108,000,000
3,834,000,000
3,971,000,000
3,983,000,000
4,119,000,000
4,628,000,000
4,675,000,000
4,742,000,000
4,656,000,000
4,749,000,000
3,789,000,000
3,819,000,000
4,460,000,000
4,511,000,000
4,425,000,000
4,382,000,000
4,342,000,000
5,874,000,000
5,724,000,000
5,825,000,000
5,954,000,000
5,966,000,000
5,900,000,000
6,092,600,000
5,775,600,000
4,360,000,000
4,560,200,000
4,722,700,000
4,763,900,000
4,771,500,000
4,670,700,000
2,585,400,000
2,226,600,000
2,222,400,000
2,134,400,000
2,030,300,000
2,173,500,000
2,280,400,000
2,226,000,000
2,261,300,000
2,550,000,000
2,549,400,000
3,006,600,000
3,047,100,000
3,071,700,000
3,031,000,000
3,063,600,000
2,839,600,000
2,390,300,000
2,347,900,000
2,283,100,000
2,278,900,000
2,433,300,000
2,268,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.